Transcriptional regulators of the human multidrug resistance 1 gene: Recent views

Biochemical Pharmacology

Volumn 64, Issue 5-6, 2002, Pages 943-948

  Labialle, Stéphane ^a   Gayet, Landry ^a   Marthinet, Eric ^a   Rigal, Dominique ^b   Baggetto, Loris G ^a  

^a INSTITUT DE BIOLOGIE ET CHIMIE DES PROTÉINES   (France)

^b ETABLISSEMENT FRANÇAIS DU SANG   (France)

Author keywords

hMDR1 gene; Multidrug resistance; P glycoprotein; Transcriptional regulation

Indexed keywords

MULTIDRUG RESISTANCE PROTEIN 1; TRANSCRIPTION FACTOR;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RESISTANCE; GENE CONTROL; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; MULTIDRUG RESISTANCE; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TREATMENT FAILURE;

DRUG RESISTANCE, MULTIPLE; GENE EXPRESSION REGULATION; HUMANS; P-GLYCOPROTEIN; PROMOTER REGIONS (GENETICS); TRANSCRIPTION, GENETIC;

EID: 0036710923     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(02)01156-5     Document Type: Article

References (62)

1. Kessel D., Botterill V., Wodinsky I. Uptake and retention of daunomycin by mouse leukemic cells as factors in drug response. Cancer Res. 28:1968;938-941.
2. Danø K. Active outward transport of daunomycin in resistant ehrlich ascites tumor cells. Biochim. Biophys. Acta. 323:1973;466-483.
3. Juliano R.L., Ling V.A. Surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim. Biophys. Acta. 455:1976;152-162.
4. Rosenberg M.F., Callaghan R., Ford R.C., Higgins C.F. Structure of the multidrug resistant P-glycoprotein to 2.5 nm resolution determined by electron microscopy and image analysis. J. Biol. Chem. 272:1997;10685-10694.
5. Dong M., Ladavière L., Deleage G., Penin F., Baggetto L.G. Secondary structure of P-glycoprotein from circular dichroism and prediction from its sequence. Biochim. Biophys. Acta. 1371:1998;317-334.
6. Rosenberg M.F., Velarde G., Ford R.C., Martin C., Berridge G., Kerr I.D., Callaghan R., Schmidlin A., Wooding C., Linton K.J., Higgins C.F. Repacking of the transmembrane domains of P-glycoprotein during the transport ATPase cycle. EMBO J. 20:2001;5615-5625.
7. Walker J.E., Saraste M., Runswick M.J., Gay N.J. Distantly related sequences in the α- and β-subunits of ATPsynthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold. EMBO J. 1:1982;945-951.
8. Higgins C.F., Hyde S.C., Mimmack M.M., Gileadi U., Gill D.R., Gallagher M.P. Binding protein-dependent transport systems. J. Bioenerg. Biomembr. 22:1990;571-593.
9. Gros P., Ben Neriah Y.B., Croop J.M., Housman D.E. Isolation and expression of a complementary DNA that confers multidrug resistance. Nature. 323:1986;728-731.
10. Shen D.W., Fojo A., Chin J.E., Roninson I.B., Richert N., Pastan I., Gottesman M.M. Human multidrug-resistant cell lines: increased mdr1 expression can precede gene amplification. Science. 232:1986;643-645.
11. Fojo A.T., Whang-Peng J., Gottesman M.M., Pastan I. Amplification of DNA sequences in human multidrug-resistant KB carcinoma cells. Proc. Natl. Acad Sci. U.S.A. 82:1985;7661-7665.
12. de Bruijn M.H.L., Van der Bliek A.M., Biedler J.L., Borst P. Differential amplification and disproportionate expression of five genes in three multidrug-resistant Chinese hamster lung cell lines. Mol. Cell Biol. 6:1986;4717-4722.
13. Ueda K., Pastan I., Gottesman M.M. Isolation and sequence of the promoter region of the human multidrug resistance (P-glycoprotein) gene. J. Biol. Chem. 262:1987;17432-17436.
14. Mickley L.A., Spengler B.A., Knutsen T.A., Biedler J.L., Fojo T. Gene rearrangement: a novel mechanism for MDR-1 gene activation. J. Clin. Invest. 99:1997;1947-1957.
15. Ince T.A., Scotto K.W. Transcriptional regulation of multidrug-resistant genes. Encyclopedia of cancer. III:1997;1751-1764.
16. Van Groenigen M., Valentijn L.J., Baas F. Identification of a functional initiator sequence in the human MDR1 promoter. Biochim. Biophys. Acta. 1172:1993;138-146.
17. Javahery R., Khachi A., Lo K., Zenzie-Gregory B., Smale S.T. DNA sequence requirements for transcriptional initiator activity in mammalian cells. Mol. Cell Biol. 14:1994;116-127.
18. Smale S.T., Baltimore D. The "initiator" as a transcription control element. Cell. 57:1989;103-113.
19. Cornwell M.M., Smith D.E. Sp1 activates the MDR1 promoter through one of the two distinct G-rich regions that modulate promoter activity. J. Biol. Chem. 268:1993;19505-19511.
20. Lania L., Majello B., De Luca P. Transcriptional regulation by the Sp family proteins. Int. J. Biochem. Cell Biol. 29:1997;1313-1323.
21. McCoy C., Smith D.E., Cornwell M.M. TPA activation of the MDR1 promoter is mediated by EGR-1. Mol. Cell Biol. 15:1995;6100-6108.
22. McCoy C., McGee S.B., Cornwell M.M. The Wilms' tumor suppressor WT1 inhibits 12-O-tetradecanoylphorbol-13-acetate activation of the multidrug resistance-1 promoter. Cell Growth Differ. 10:1999;377-386.
23. Harrington M.A., Konicek B., Song A., Xia X.L., Fredericks W.J., Rauscher F.J III Inhibition of colony-stimulating factor-1 promoter activity by the product of the Wilms' tumor locus. J. Biol. Chem. 268:1993;21271-21275.
24. Moshier J.A., Skunca M., Wu W., Boppana S.M., Rauscher F.J III, Dosescu J. Regulation of ornithine decarboxylase gene expression by the Wilms' tumor suppressor WT1. Nucleic Acids Res. 24:1996;1149-1157.
25. Ohga T., Koike K., Ono M., Makino Y., Itagaki Y., Tanimoto M., Kuwano M., Kohno K. Role of the human Y box-binding protein YB-1 in cellular sensitivity to the DNA-damaging agents cisplatin, mitomycin C, and ultraviolet light. Cancer Res. 56:1996;4224-4228.
26. Sundseth R., MacDonald G., King A.C. DNA elements recognizing NF-Y and Sp1 regulate the human multidrug-resistance gene promoter. Mol. Pharmacol. 51:1997;963-971.
27. Jin S., Scotto K.W. Transcriptional regulation of the MDR1 gene by histone acetyltransferase/deacetylase is mediated by NF-Y. Mol. Cell Biol. 18:1998;4377-4384.
28. Hu Z., Jin S., Scotto K.W. Transcriptional activation of the MDR1 gene by UV irradiation. Role of NF-Y and Sp1. J. Biol. Chem. 275:2000;2979-2985.
29. Wolffe A.P. Structural and functional properties of the evolutionarily ancient Y-box family of nucleic acid binding proteins. Bioessays. 16:1994;245-251.
30. Skabkin M.A., Evdokimova V., Thomas A.A., Ovchinnikov L.P. The major messenger ribonucleoprotein particle protein p50 (YB-1) promotes nucleic acid strand annealing. J. Biol. Chem. 276:2001;44841-44847.
31. Evdokimova V., Ruzanov P., Imataka H., Raught B., Svitkin Y., Ovchinnikov L.P., Sonenberg N. The major mRNA-associated protein YB-1 is a potent 5′ cap-dependent mRNA stabilizer. EMBO J. 20:2001;5491-5502.
32. Roder K., Wolf S.S., Larkin K.J., Schweizer M. Interaction between the two ubiquitously expressed transcription factors NF-Y and Sp1. Gene. 234:1999;61-69.
33. Linhoff M.W., Wright K.L., Ting J.P. CCAAT-binding factor NF-Y and RFX are required for in vivo assembly of a nucleoprotein complex that spans 250 base pairs: the invariant chain promoter as a model. Mol. Cell Biol. 17:1997;4589-4596.
34. Mantovani R. A survey of 178 NF-Y binding CCAAT boxes. Nucleic Acids Res. 26:1998;1135-1143.
35. Nguyen K.T., Liu B., Ueda K., Gottesman M.M., Pastan I., Chin K.V. Transactivation of the human multidrug resistance (MDR1) gene promoter by p53 mutants. Oncol. Res. 6:1994;71-77.
36. Chin K.V., Ueda K., Pastan I., Gottesman M.M. Modulation of the activity of the promoter of the human MDR1 gene by Ras and p53. Science. 255:1992;459-462.
37. Johnson R.A., Ince T.A., Scotto K.W. Transcriptional repression by p53 through direct binding to a novel DNA element. J. Biol. Chem. 276:2001;27716-27720.
38. Sampath J., Sun D., Kidd V.J., Grenet J., Gandhi A., Shapiro L.H., Wang Q., Zambetti G.P., Schuetz J.D. Mutant p53 cooperates with ETS and selectively up-regulates human MDR1 not MRP1. J. Biol. Chem. 276:2001;39359-39367.
39. Goldsmith M.E., Gudas J.M., Schneider E., Cowan K.H. Wild type p53 stimulates expression from the human multidrug resistance promoter in a p53-negative cell line. J. Biol. Chem. 270:1995;1894-1898.
40. May P., May E. Twenty years of p53 research: structural and functional aspects of the p53 protein. Oncogene. 18:1999;7621-7636.
41. Daschner P.J., Ciolino H.P., Plouzek C.A., Yeh G.C. Increased AP-1 activity in drug resistant human breast cancer MCF-7 cells. Breast Cancer Res. Treat. 53:1999;229-240.
42. Ogretmen B., Safa A.R. Negative regulation of MDR1 promoter activity in MCF-7 but not in multidrug resistant MCF-7/Adr cells by cross-coupled NF-kappa B/p65 and c-Fos transcription factors and their interaction with the CAAT region. Biochemistry. 38:1999;2189-2199.
43. Combates N.J., Rzepka R.W., Chen Y.N., Cohen D. NF-IL6 a member of the C/EBP family of transcription factors binds and trans-activates the human MDR1 gene promoter. J. Biol. Chem. 269:1994;29715-29719.
44. Chin K.V., Tanaka S., Darlington G., Pastan I., Gottesman M.M. Heat shock and arsenite increase expression of the multidrug resistance (MDR1) gene in human renal carcinoma cells. J. Biol. Chem. 265:1990;221-226.
45. Kioka N., Yamano Y., Komano T., Ueda K. Heat-shock responsive elements in the induction of the multidrug resistance gene (MDR1). FEBS Lett. 301:1992;37-40.
46. Miyazaki M., Kohno K., Uchiumi T., Tanimura H., Matsuo K., Nasu M., Kuwano M. Activation of human multidrug resistance-1 gene promoter in response to heat shock stress. Biochem. Biophys. Res. Commun. 187:1992;677-684.
47. Vilaboa N.E., Galan A., Troyano A., de Blas E., Aller P. Regulation of multidrug resistance 1 (MDR1)/P-glycoprotein gene expression and activity by heat-shock transcription factor 1 (HSF1). J. Biol. Chem. 275:2000;24970-24976.
48. Roose J., Clevers H. TCF transcription factors: molecular switches in carcinogenesis. Biochim. Biophys. Acta. 1424:1999;M23-37.
49. Soler C., Grangeasse C., Baggetto L.G., Damour O. Dermal fibroblast proliferation is improved by beta-catenin overexpression and inhibited by E-cadherin expression. FEBS Lett. 442:1999;178-182.
50. Yamada T., Takaoka A.S., Naishiro Y., Hayashi R., Maruyama K., Maesawa C., Ochiai A., Hirohashi S. Transactivation of the multidrug resistance 1 gene by T-cell factor 4/beta-catenin complex in early colorectal carcinogenesis. Cancer Res. 60:2000;4761-4766.
51. Geick A., Eichelbaum M., Burk O. Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin. J. Biol. Chem. 276:2001;14581-14587.
52. Synold T.W., Dussault I., Forman B.M. The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux. Nat. Med. 7:2001;584-590.
53. Ogura M., Takatori T., Tsuruo T. Purification and characterization of NF-R1 that regulates the expression of the human multidrug resistance (MDR1) gene. Nucleic Acids Res. 20:1992;5811-5817.
54. Takatori T., Ogura M., Tsuruo T. Purification and characterization of NF-R2 that regulates the expression of the human multidrug resistance (MDR1) gene. Jpn. J. Cancer Res. 84:1993;298-303.
55. Ogretmen B., Safa A.R. Identification and characterization of the MDR1 promoter-enhancing factor 1 (MEF1) in the multidrug resistant HL60/VCR human acute myeloid leukemia cell line. Biochemistry. 39:2000;194-204.
56. Marthinet E., Divita G., Bernaud J., Rigal D., Baggetto L.G. Modulation of the typical multidrug resistance phenotype by targeting the MED-1 region of human MDR1 promoter. Gene Ther. 7:2000;1224-1233.
57. Labialle S, Marthinet E, Gayet L, Rigal D, Baggetto LG. Characterization of a new activating transcriptional element on the human MDR1 gene promoter in multidrug resistant cancer cells. In: Cell signaling, transcription and translation as therapeutic targets. Proceedings of the Third Congress on Signal Transduction, Luxembourg 2002;262.
58. Ackerman S.L., Minden A.G., Williams G.T., Bobonis C., Yeung C.Y. Functional significance of an overlapping consensus binding motif for Sp1 and Zif268 in the murine adenosine deaminase gene promoter. Proc. Natl. Acad. Sci. U.S.A. 88:1991;7523-7527.
59. Merika M., Thanos D. Enhanceosomes. Curr. Opin. Genet Dev. 11:2001;205-208.
60. Brivanlou A.H., Darnell J.E. Jr. Signal transduction and the control of gene expression. Science. 295:2002;813-818.
61. Kusaba H., Nakayama M., Harada T., Nomoto M., Kohno K., Kuwano M., Wada M. Association of 5′ CpG demethylation and altered chromatin structure in the promoter region with transcriptional activation of the multidrug resistance 1 gene in human cancer cells. Eur. J. Biochem. 262:1999;924-932.
62. El-Osta A., Kantharidis P., Zalcberg J.R., Wolffe A.P. Precipitous release of methyl-CpG binding protein 2 and histone deacetylase 1 from the methylated human multidrug resistance gene (MDR1) on activation. Mol. Cell Biol. 22:2002;1844-1857.